Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group.

Authors

J Hassett
G F. Gjerset
J W. Mosley
Mary A. Fletcher, Nova Southeastern UniversityFollow
E Donegan
J W. Parker
R B. Counts
L M. Aledort
H Lee
M C. Pike

Publication Title

Blood

ISSN

0006-4971

Publication Date

8-1-1993

Volume

82

Issue

4

First Page

1351

Last Page

1357

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Hassett, J; Gjerset, G F.; Mosley, J W.; Fletcher, Mary A.; Donegan, E; Parker, J W.; Counts, R B.; Aledort, L M.; Lee, H; and Pike, M C., "Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group." (1993). Faculty Articles. 121.
https://nsuworks.nova.edu/hpd_com_faculty_articles/121